NEW YORK, NY — (Marketwire) — 07/27/11 — provides members with proprietary analysis of over 10,000 stocks which is updated every day. Today, members can receive their complimentary stock analysis on (NASDAQ: PPDI) and (NYSE: LH). Sign up now on to get your free reports on these stocks.
With the economy slowly improving, some companies in the Medical Laboratories and Research sector have been able to bounce back from the lows of the recession. Signs of weakness in the sector continue though, with several cancellations in upcoming clinical research trials negatively affecting stocks of companies like Pharmaceutical Product Development Inc.
brings investors free classic analysis on Pharmaceutical Product Development Inc., Laboratory Corp. of America Holdings and other companies within the Medical Laboratories & Research industry. This type of analysis is only a fragment of the information members have available to them. To learn more we encourage investors to sign up at .
Pharmaceutical Product Development recently made news when reports came out that a sale of the company may be in the works. gives traders a unique insight about by registering now at .
The weak economy has affected individual patients as well who seem to be visiting clinics less often to keep their personal medical costs down. Companies in the sector like Laboratory Corp. of America Holdings which provide lab tests and results for physicians and individual patients have seen testing volumes fall as a result of patients shying away from doctor visits. gives traders a unique insight about by registering now at .
Laboratory Corp. is currently looking to buy DNA-testing services company Orchid, and it is working through information requests with the Federal Trade Commission.
Signal Watch-s #1 goal is to help customers successfully engage the markets. For over 20 years, we have been developing the most powerful trading software available anywhere. But the software is only part of our mission. We also provide education and customer support designed to enable our customers to take control of their financial future.
Read our disclaimer by clicking on the following link